JPH0336808B2 - - Google Patents

Info

Publication number
JPH0336808B2
JPH0336808B2 JP61304058A JP30405886A JPH0336808B2 JP H0336808 B2 JPH0336808 B2 JP H0336808B2 JP 61304058 A JP61304058 A JP 61304058A JP 30405886 A JP30405886 A JP 30405886A JP H0336808 B2 JPH0336808 B2 JP H0336808B2
Authority
JP
Japan
Prior art keywords
escin
edema
dose
plasma
lymphorrhoea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61304058A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6366127A (ja
Inventor
Maadausu Rorufu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Madaus Holding GmbH
Original Assignee
Madaus AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus AG filed Critical Madaus AG
Publication of JPS6366127A publication Critical patent/JPS6366127A/ja
Publication of JPH0336808B2 publication Critical patent/JPH0336808B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
JP61304058A 1975-07-11 1986-12-22 Ｘ線回折無定形エスシンを含有する抗滲出剤 Granted JPS6366127A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2530953.9 1975-07-11
DE2530953A DE2530953C2 (de) 1975-07-11 1975-07-11 Verfahren zur Herstellung von röntgenamorphem Aescin, nach diesem Verfahren erhältliches röntgenamorphes Aescin und dieses enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
JPS6366127A JPS6366127A (ja) 1988-03-24
JPH0336808B2 true JPH0336808B2 (enExample) 1991-06-03

Family

ID=5951225

Family Applications (2)

Application Number Title Priority Date Filing Date
JP51082846A Granted JPS5234915A (en) 1975-07-11 1976-07-12 Xxray diffraction amorphous escin* its preparation and ittcontaining antitransudation agent
JP61304058A Granted JPS6366127A (ja) 1975-07-11 1986-12-22 Ｘ線回折無定形エスシンを含有する抗滲出剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP51082846A Granted JPS5234915A (en) 1975-07-11 1976-07-12 Xxray diffraction amorphous escin* its preparation and ittcontaining antitransudation agent

Country Status (20)

Country Link
JP (2) JPS5234915A (enExample)
AU (1) AU510463B2 (enExample)
BE (1) BE844053A (enExample)
BG (1) BG27379A3 (enExample)
CA (1) CA1064903A (enExample)
CS (1) CS208184B2 (enExample)
DE (1) DE2530953C2 (enExample)
ES (1) ES449748A1 (enExample)
FI (1) FI62099C (enExample)
FR (1) FR2316961A1 (enExample)
GB (1) GB1550845A (enExample)
HK (1) HK33681A (enExample)
HU (1) HU174603B (enExample)
PH (1) PH13989A (enExample)
PL (1) PL99028B1 (enExample)
PT (1) PT65302B (enExample)
RO (1) RO70354A (enExample)
SU (1) SU786857A3 (enExample)
YU (1) YU41812B (enExample)
ZA (1) ZA764065B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1252201B (it) * 1991-12-12 1995-06-05 Dompe Farmaceutici Spa S-carbossimetilcisteina sale di lisina monoidrato e procedimento per la sua preparazione.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE302543C (enExample) *
NL301747A (enExample) * 1962-12-14
YU37063B (en) * 1971-12-06 1984-08-31 Lek Tovarna Farmacevtskih Process for preparing x-ray amorphous water-sulubleascin
DE2357226A1 (de) * 1973-11-16 1975-05-28 Merck Patent Gmbh Verfahren zur herstellung von wasserloeslichem beta-aescin

Also Published As

Publication number Publication date
BG27379A3 (bg) 1979-10-12
CS208184B2 (en) 1981-08-31
GB1550845A (en) 1979-08-22
FI761895A7 (enExample) 1977-01-12
AU1572976A (en) 1978-01-12
PL99028B1 (pl) 1978-06-30
BE844053A (fr) 1977-01-12
FR2316961B1 (enExample) 1984-04-20
FI62099B (fi) 1982-07-30
YU41812B (en) 1988-02-29
YU167076A (en) 1983-06-30
FI62099C (fi) 1982-11-10
HU174603B (hu) 1980-02-28
ZA764065B (en) 1977-07-27
FR2316961A1 (fr) 1977-02-04
SU786857A3 (ru) 1980-12-07
JPS6221765B2 (enExample) 1987-05-14
JPS6366127A (ja) 1988-03-24
PT65302B (de) 1977-12-13
CA1064903A (en) 1979-10-23
PH13989A (en) 1980-11-28
DE2530953C3 (de) 1994-07-07
JPS5234915A (en) 1977-03-17
DE2530953A1 (de) 1977-01-27
DE2530953C2 (de) 1994-07-07
AU510463B2 (en) 1980-06-26
RO70354A (ro) 1982-03-24
HK33681A (en) 1981-07-24
ES449748A1 (es) 1977-08-16
PT65302A (de) 1976-07-01

Similar Documents

Publication Publication Date Title
SU1544190A3 (ru) Способ получени тиазоло [4,5-с] хинолина или его кислотно-аддитивных солей
AU721709B2 (en) Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
US5158883A (en) Method of using aminoarginine to block nitric oxide formation in vitro
IL42764A (en) S-adenosyl-2-methionine tri-p-toluene sulfonate,its preparation and therapeutic compositions containing it
JPS6084251A (ja) 鎮痛用新規化合物および組成物
KR100422276B1 (ko) 치환된카복실산형태의음이온성비마취성진통제의모르핀염및디아모르핀염,이들의제조방법,이들의용도및이들염을포함하는제제
DE68904507T2 (de) Verwendung von inositoltriphosphat bei der behandlung der beschaedigung von gewebe.
WO2025092323A1 (zh) 一种左奥硝唑磷酸酯晶型ⅰ及其制备方法和用途
US4150111A (en) Enteric coated magnesium chloride
JPH0336808B2 (enExample)
CN108451909B (zh) 一种酮咯酸氨丁三醇片剂
EP0351784B1 (en) Therapeutic use of the isopropyl ester derivative of monosialoganglioside in nervous pathologies with an inflammatory component
RU2036642C1 (ru) Способ получения бронхолитической лекарственной композиции пролонгированного действия на основе теофиллина
RU2072847C1 (ru) Средство для профилактики и лечения отморожений
CN116444377A (zh) 一种氧化氮供体型曲前列尼尔类衍生物及其药物组合物和用途
CN102079715B (zh) 一种二元酯酸的赖氨酸盐化合物,其制备方法和药物应用
US4293541A (en) Compounds
RU2663836C1 (ru) L-Энантиомер 2-этил-6-метил-3-гидроксипиридиния гидроксибутандиоата, обладающий церебропротекторной активностью
JPH0141606B2 (enExample)
RU2780646C1 (ru) Новая кристаллическая форма 7-бром-1-(гидразинокарбонил)метил-5-фенил-1,2-дигидро-3h-1,4-бензодиазепин-2-она и ее фармацевтическое применение
RU2187303C2 (ru) Способ получения таблеток диуманкала - forte по 0,01 г
CN114478517B (zh) 一种盐酸巴马汀-阿司匹林超分子化合物
CN119836428A (zh) 新型苯磷硫胺胆碱盐
US3903269A (en) Cholinomimetic compositions containing a polymer derivative of 1-methyl-5-{8 5-oxo-4-ethyl-tetrahydrofuryl-(3)-methyl{9 -imidazole with cellulose glycolic acid
ES3041301T3 (en) Pharmaceutical composition comprising benzocaine with enhanced stability